← Back to Search

Smartphone App for Smoking Cessation

N/A
Waitlist Available
Led By Jennifer A Minnix
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
MD Anderson patient between the ages of 18 to 65
Willing to set a quit date in the next 30 days
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 weeks from start of study
Awards & highlights

Study Summary

This trial is testing if smartphone apps can help people quit smoking.

Who is the study for?
This trial is for English-speaking MD Anderson patients aged 18-65 who smoke daily, own an iOS device with regular app usage, and are willing to set a quit date within 30 days. They must have smoked for at least a year and either currently have or previously had depressive symptoms. People can't join if they're in another smoking cessation program or have health issues that make the study unsafe for them.Check my eligibility
What is being tested?
The study is testing how effective smartphone apps are in helping smokers quit. Participants will use these apps as part of their smoking cessation treatment to see if it enhances their ability to stop smoking.See study design
What are the potential side effects?
Since this trial involves using a mobile application and answering questionnaires, there aren't typical medical side effects. However, participants may experience stress or frustration related to quitting smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a patient at MD Anderson, aged between 18 and 65.
Select...
I am willing to commit to quitting smoking within the next 30 days.
Select...
I have or had depression symptoms.
Select...
I can speak and understand English well.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 weeks from start of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks from start of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Smoke
Evidence of improved mood in KickAsh and Breathe2Relax groups
Evidence of increased activity level in KickAsh and Breathe2Relax groups
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group II (Breathe2Relax smartphone mobile application)Experimental Treatment2 Interventions
Participants receive Breathe2Relax smartphone mobile application designed to help improve mood and increase level of enjoyable activities over 8 weeks.
Group II: Group I (KickAsh smartphone mobile application)Experimental Treatment2 Interventions
Participants receive KickAsh smartphone mobile application designed to help the learning of relaxation skills over 8 weeks.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,967 Previous Clinical Trials
1,804,778 Total Patients Enrolled
10 Trials studying Tobacco Use Disorder
4,421 Patients Enrolled for Tobacco Use Disorder
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,643 Total Patients Enrolled
93 Trials studying Tobacco Use Disorder
1,682,806 Patients Enrolled for Tobacco Use Disorder
Jennifer A MinnixPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
85 Total Patients Enrolled
1 Trials studying Tobacco Use Disorder
85 Patients Enrolled for Tobacco Use Disorder

Media Library

Internet-Based Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03519451 — N/A
Tobacco Use Disorder Research Study Groups: Group I (KickAsh smartphone mobile application), Group II (Breathe2Relax smartphone mobile application)
Tobacco Use Disorder Clinical Trial 2023: Internet-Based Intervention Highlights & Side Effects. Trial Name: NCT03519451 — N/A
Internet-Based Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03519451 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who are the ideal candidates for this clinical research study?

"This clinical trial is enrolling 24 patients diagnosed with depression, aged between 18 and 65. Criteria for enrolment include: being an MD Anderson patient, smoking at least one cigarette or e-cigarette per day in the past year, willingness to set a quit date within 30 days, no prior engagement in cessation treatment other than MDACC Tobacco Treatment Program; current/past elevated depressive symptoms (PHQ 2 = or > 1); English fluency; ownership of iOS device running version 9.0+ and regular app usage on it."

Answered by AI

Is the current research endeavor accepting participants who are over 30 years of age?

"To participate in this medical experiment, patients must be aged between 18 and 65 years."

Answered by AI

Is enrollment currently open for this experimental research?

"As per clinicaltrials.gov, this research is no longer seeking candidates since it has completed recruitment; the trial was initially posted on April 25th 2018 and a final update was published on September 22nd 2022. Nevertheless, there are 1244 other studies currently accepting volunteers across the country."

Answered by AI

Who else is applying?

What state do they live in?
Texas
What site did they apply to?
M D Anderson Cancer Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I have tried patches, gum but does not work. I've had other treatments but seems to work...
PatientReceived no prior treatments
I really want to quit and nothing else has worked.
PatientReceived no prior treatments
~2 spots leftby Dec 2024